Cita APA (7a ed.)
Boucek, J., & Turner, J. (2005). Validation of prospective whole-body bone marrow dosimetry by SPECT/CT multimodality imaging in131I-anti-CD20 rituximab radioimmunotherapy of non-Hodgkin’s lymphoma. European Journal of Nuclear Medicine & Molecular Imaging, 32(4), 458-470.
Cita Chicago Style (17a ed.)
Boucek, Jan, y J. Turner. "Validation of Prospective Whole-body Bone Marrow Dosimetry by SPECT/CT Multimodality Imaging In131I-anti-CD20 Rituximab Radioimmunotherapy of Non-Hodgkin’s Lymphoma." European Journal of Nuclear Medicine & Molecular Imaging 32, no. 4 (2005): 458-470.
Cita MLA (9a ed.)
Boucek, Jan, y J. Turner. "Validation of Prospective Whole-body Bone Marrow Dosimetry by SPECT/CT Multimodality Imaging In131I-anti-CD20 Rituximab Radioimmunotherapy of Non-Hodgkin’s Lymphoma." European Journal of Nuclear Medicine & Molecular Imaging, vol. 32, no. 4, 2005, pp. 458-470.
Precaución: Estas citas no son 100% exactas.